Depré C, Veitch K, Hue L
Hormone and Metabolic Research Unit, University of Louvain Medical School, Brussels, Belgium.
Acta Cardiol. 1993;48(1):147-64.
Fructose 2,6-bisphosphate (Fru-2,6-P2) is the most potent stimulator of 6-phosphofructo-1-kinase (PFK-1), a key enzyme of glycolysis. We studied whether this regulator is involved in the changes of glycolysis that can be induced experimentally in the isolated working rat heart. The glycolytic flux was assessed by the rate of detritiation of [2-3H]- and [3-3H]glucose, by lactate output and by the changes in glycogen content. A 20-40% increase in Fru-2,6-P2 content was observed when glycolysis was stimulated by increasing either the workload (by increasing both preload and afterload) or the concentration of glucose (from 2 to 11 mM), or by adding 7 microM insulin. Anoxia decreased the external work developed by the heart, stimulated glycolysis by activating glycogenolysis, but did not increase Fru-2,6-P2. The increase of Fru-2,6-P2 content observed after insulin, high workload or glucose load might be related to a stimulation of glucose transport, and/or an activation of 6-phosphofructo-2-kinase (PFK-2), the enzyme responsible for the synthesis of Fru-2,6-P2. Addition to the perfusate of 0.5 to 10 mM lactate, which is a preferred substrate for the heart, with pyruvate in a 10:1 ratio, induced a dose-dependent inhibition of the glycolytic flux through PFK-1, with a maximal inhibition of 75% at 5 mM lactate. The accumulation of hexose 6-phosphates without change in fructose 1,6-bisphosphate and triose-phosphates concentrations confirmed that the inhibition of glycolysis was mainly exerted on PFK-1. This inhibition resulted from a doubling of the citrate concentration, an inhibitor, and from 75% decrease in Fru-2,6-P2. Despite the inhibition of glycolysis, glucose phosphorylation was barely affected by lactate, suggesting a change in glucose metabolism. Indeed, lactate induced a dose-dependent increase in glycogen content, which doubled at 5 mM lactate, reaching the level obtained after addition of 7 microM insulin. Increased glycogen synthesis was explained by the accumulation of UDP glucose, the substrate, and glucose 6-phosphate, a stimulator of glycogen synthase. We conclude that, during aerobiosis, Fru-2,6-P2 can be regarded as a glycolytic signal which is switched on by glucose availability, workload and insulin, and which is switched off by the availability of alternative oxidative substrates such as lactate. The latter also controls glucose metabolism by diverting glucose from glycolysis to glycogen synthesis.
果糖-2,6-二磷酸(Fru-2,6-P2)是糖酵解关键酶6-磷酸果糖-1-激酶(PFK-1)最有效的刺激物。我们研究了这种调节剂是否参与了在离体工作大鼠心脏中可通过实验诱导的糖酵解变化。通过[2-³H]-和[3-³H]葡萄糖的氚化率、乳酸输出量以及糖原含量的变化来评估糖酵解通量。当通过增加工作量(增加前负荷和后负荷)、增加葡萄糖浓度(从2 mM增加到11 mM)或添加7 μM胰岛素来刺激糖酵解时,观察到Fru-2,6-P2含量增加了20 - 40%。缺氧降低了心脏产生的外部功,通过激活糖原分解刺激糖酵解,但并未增加Fru-2,6-P2。在胰岛素、高工作量或葡萄糖负荷后观察到的Fru-2,6-P2含量增加可能与葡萄糖转运的刺激和/或6-磷酸果糖-2-激酶(PFK-2,负责Fru-2,6-P2合成的酶)的激活有关。向灌注液中添加0.5至10 mM乳酸(心脏的一种首选底物,与丙酮酸的比例为10:1)会导致通过PFK-1的糖酵解通量呈剂量依赖性抑制,在5 mM乳酸时最大抑制率为75%。己糖6-磷酸的积累而果糖-1,6-二磷酸和磷酸丙糖浓度无变化,证实糖酵解的抑制主要作用于PFK-1。这种抑制是由于抑制剂柠檬酸浓度加倍以及Fru-2,6-P2减少75%所致。尽管糖酵解受到抑制,但葡萄糖磷酸化几乎不受乳酸影响,这表明葡萄糖代谢发生了变化。实际上,乳酸诱导糖原含量呈剂量依赖性增加,在5 mM乳酸时增加了一倍,达到添加7 μM胰岛素后获得的水平。糖原合成增加是由于底物UDP葡萄糖和糖原合酶刺激物葡萄糖6-磷酸的积累所致。我们得出结论,在需氧条件下,Fru-2,6-P2可被视为一种糖酵解信号,它由葡萄糖可用性、工作量和胰岛素开启,并由替代氧化底物如乳酸的可用性关闭。后者还通过将葡萄糖从糖酵解转向糖原合成来控制葡萄糖代谢。